Possibilities to reduce the unwanted gastric side-effects of orally administered indomethacin in the rat.
Balint
G A
GA
Department of Neurology and Psychiatry, (Clinical Pharmacology Lab.), Albert Szent-Györgyi Medical University, Szeged, Hungary.
D000284:Administration, Oral; D000818:Animals; D003545:Cysteine / Q000494:pharmacology / Q000627:therapeutic use*; D011464:Epoprostenol / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced* / Q000517:prevention & control; D007213:Indomethacin / Q000008:administration & dosage / Q000633:toxicity*; D010865:Pilot Projects; D051381:Rats; D011919:Rats, Inbred Strains; D013276:Stomach Ulcer / Q000139:chemically induced* / Q000517:prevention & control
D011464:Epoprostenol; D003545:Cysteine; D007213:Indomethacin